| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16243 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-05 |
| filingDate |
2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01ed3dff4b5be6c7b93a7d72b0e4b094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f4a6f8ce77c8dbbe7061742ca401e3c |
| publicationDate |
2004-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004141995-A1 |
| titleOfInvention |
MHC class I-restricted and MHC class II-restricted EBNA1 peptides |
| abstract |
The present invention is directed to HLA-DP3 and HLA-B8 restricted peptides from EBNA1. Furthermore, the present invention relates to generating T cells specific for EBNA1 or antigen-presenting cell that present EBNA1 peptides. The present invention is also directed to methods for stimulating effector cell responses for cellular immunotherapy. Cellular immunotherapy can successfully prevent or treat various viral infections and tumors related to Epstein-Barr virus, such as Hodgkin's lymphoma. The invention is also directed to vaccines including EBNA1 peptide epitopes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007196389-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110638787-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1948232-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009130134-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011239787-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1948232-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006082313-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013063713-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006082313-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2881746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105693828-A |
| priorityDate |
2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |